Logo of National Eczema Association mobile menu icon
Icon link to National Eczema's Instagram feed. Icon link to National Eczema's YouTube channel. Icon link to National Eczema's Facebook page. Icon link to National Eczema's Twitter feed. Icon link to National Eczema's inspire.com page. Search Icon to search the site

Get the tools and support you need to best manage your eczema

  • This field is for validation purposes and should be left unchanged.


Swiss scientists identify link between skin fungi imbalance, atopic dermatitis

The Swiss scientists theorized that the same immune cells that protect us against the normally harmless Malassezia fungus might also play a fundamental role in triggering atopic dermatitis.

Read More

California dermatologist pioneers a simple, non-prescription treatment for atopic dermatitis

While not a cure, Orliderm™ has brought relief to hundreds of children and adults with moderate to severe atopic dermatitis.

Read More

Colorado researchers urge raising the bar for treating severe eczema

The researchers suggest doctors combine basic skincare techniques with cutting-edge treatments to maximize the well-being of their patients.

Read More

It’s time for our annual treatment roundup

In the “Golden Age of Eczema,” people with atopic dermatitis have more treatment options than ever before, with even more drugs making their way to pharmacy shelves.

Read More

Can probiotics help kids with atopic dermatitis?

New evidence shows that Lactobacillus-containing probiotic strains may reduce disease severity in children age 3 and under.

Read More

Low-dose Naltrexone for atopic dermatitis?

Dermatologists discuss the potential efficacy of prescribing an opioid antagonist to address the problem of itch in atopic dermatitis.

Read More

AD topical cream Jakafi moving on to phase 3 clinical trial

A new, nonsteroidal topical cream for AD called Jakafi (ruxolitinib) may soon hit pharmacy shelves.

Read More

Merging traditional and alternative therapies for eczema relief

Integrative medicine is gaining traction in the health care field, specifically the idea of balancing conventional treatments with complementary therapies for a whole-body approach to treating eczema.

Read More

Biologics may show greater risk for infection than systemics

Off-label use of biologic treatments for atopic dermatitis may double the risk for serious infection compared to systemic treatments, researchers found.

Read More

Dupixent approved for treating eczema patients aged 12 to 17

The first biologic for treating moderate to severe atopic dermatitis was just approved for teens.

Read More